NI
Nextech Invest Portfolio holdings
AUM
$528M
This Quarter Return
+13.41%
1 Year Return
-0.88%
3 Year Return
+164%
5 Year Return
–
10 Year Return
–
AUM
$294M
AUM Growth
+$294M
(+23%)
Cap. Flow
+$37M
Cap. Flow
% of AUM
12.58%
Top 10 Holdings %
Top 10 Hldgs %
97.8%
Holding
13
New
1
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
Oric Pharmaceuticals
ORIC
|
$33.3M |
| 2 |
Relay Therapeutics
RLAY
|
$4.06M |
Top Sells
| 1 |
PMV Pharmaceuticals
PMVP
|
$313K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$7.1B
| $129M | 44% | 4,839,529 | – | – |
|
2
Tyra Biosciences
TYRA
$675M
| $42.9M | 14.58% | 2,518,582 | – | – |
|
|
3
Oric Pharmaceuticals
ORIC
$994M
| $33.3M | 11.3% | +4,285,714 | New | +$33.3M |
|
|
EQRX
4
DELISTED
EQRx, Inc. Common Stock
EQRX
| $24.4M | 8.28% | 13,104,424 | – | – |
|
5
Cullinan Oncology
CGEM
$445M
| $13.1M | 4.47% | 1,221,145 | – | – |
|
6
ARS Pharmaceuticals
SPRY
$1.15B
| $12.8M | 4.35% | 1,910,029 | – | – |
|
|
7
Relay Therapeutics
RLAY
$619M
| $11.9M | 4.05% | 948,659 +323,174 | +52% | +$4.06M |
|
8
Arvinas
ARVN
$568M
| $7.13M | 2.42% | 287,251 | – | – |
|
|
KNTE
9
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $7.06M | 2.4% | 2,329,480 | – | – |
|
|
THRX
10
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $5.7M | 1.94% | 611,310 | – | – |
|
|
11
PMV Pharmaceuticals
PMVP
$74.2M
| $2.95M | 1% | 471,284 -50,000 | -10% | -$313K |
|
|
KRON
12
DELISTED
Kronos Bio
KRON
| $2.5M | 0.85% | 1,451,537 | – | – |
|
13
C4 Therapeutics
CCCC
$185M
| $1.03M | 0.35% | 375,857 | – | – |
|